reference/18877850

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18877850

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1471-2407
issueIdentifier	1
pageRange	485-
publicationName	BMC Cancer
startingPage	485
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6adff80f15f30fc11614fbc6a2cd2166 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_95d5213a9667c5dc618dc58ed4ad3a85 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a4a4d52950e33267ecdc80a8f3c095ea http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_665c6efce5eca061f87bb5cdb2b63a10 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0800f83fec9d5028489f572f0a35022c
bibliographicCitation	Lobo NC, Gedye C, Apostoli AJ, Brown KR, Paterson J, Stickle N, Robinette M, Fleshner N, Hamilton RJ, Kulkarni G, Zlotta A, Evans A, Finelli A, Moffat J, Jewett MA, Ailles L. Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine. BMC Cancer. 2016 Jul 16;16():485. PMID: 27422173; PMCID: PMC4947293.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f15c1e620a66f6b17c13b77e1245fce2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_391a196b8294451b1e6f50f8f995db5e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8470514635d270149f47a3b5c7e7bf03 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86388c913f4798fcd0f54653dc39bd45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e60226c1f334a917425a2e3fe9ab763d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a748b102466174f20fb8bd1747b1769b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7289-8882 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1629-4352 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ad1f93fc7755a50e733be11fb7a3bf4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_778a1127a60e8da0c99383426535d77f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c605c3e5c60ba3ced036ded60257cc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c4a867b743873dd1818c6f4ed3a0a23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_283f3131fc194cdbfa985cf6c46d8c53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a36450373835c209a82c68d3677aabce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f1397b4349fb4570f620f7428bf1044 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0cdc2d3c62d9488acde6bedcfa497bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0294f8ff03bbae4019cf78fd811a458
date	2016-07-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/27422173 https://doi.org/10.1186/s12885-016-2539-z https://pubmed.ncbi.nlm.nih.gov/PMC4947293
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020 https://portal.issn.org/resource/ISSN/1471-2407
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002292Q000235 http://id.nlm.nih.gov/mesh/D061251Q000379 http://id.nlm.nih.gov/mesh/D002292Q000473 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D007680Q000235 http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D057285Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005434 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016688 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D059467 http://id.nlm.nih.gov/mesh/D007150 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D064593 http://id.nlm.nih.gov/mesh/D020869 http://id.nlm.nih.gov/mesh/D016513
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3453a5d8c5baa0d0e6382e0d81213cb6

Showing number of triples: 1 to 61 of 61.